Evidence that SIZN1 is a candidate X-linked mental retardation gene.
An estimated 1-3% of individuals within the United States are diagnosed with mental retardation (MR), yet the cause is unknown in nearly 50% of the patients. While several environmental, genetic and combined teratogenetic etiologies have been identified, many causative genes remain to be identified. Furthermore, the pathogenetic mechanisms underlying MR are known for very few of these genes. Males have a much higher incidence of MR implicating genes on the X-chromosome. We have recently identified a novel gene, SIZN1, on the X-chromosome and showed that it functions in modulating the BMP signaling pathway. Furthermore, we have shown this gene is necessary for basal forebrain cholinergic neuron (BFCN) specific gene expression. Given that cognitive function is impaired when BFCNs are lost or functionally disrupted, we undertook a screen of cognitively impaired males for SIZN1 mutations. We report on four different sequence variants in SIZN1 in 11 individuals with nonsyndromic X-linked mental retardation (XLMR). Our data implicate SIZN1 as a candidate gene for XLMR and/or as a neurocognitive functional modifier.
Cho
Ginam
G
Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
Bhat
Shambhu S
SS
Gao
Jinsong
J
Collins
Julianne S
JS
Rogers
R Curtis
RC
Simensen
Richard J
RJ
Schwartz
Charles E
CE
Golden
Jeffrey A
JA
Srivastava
Anand K
AK
D000595:Amino Acid Sequence; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000378:metabolism; D002874:Chromosome Mapping; D041321:Chromosomes, Human, X / Q000235:genetics*; D003071:Cognition; D014644:Genetic Variation; D006801:Humans; D047468:Immunoprecipitation; D008297:Male; D038901:X-Linked Intellectual Disability / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D016548:Prosencephalon / Q000503:physiopathology; D015398:Signal Transduction; D014157:Transcription Factors / Q000737:chemistry / Q000235:genetics* / Q000502:physiology
D019485:Bone Morphogenetic Proteins; D014157:Transcription Factors; C532851:ZCCHC12 protein, human
Biotechniques. 2003 May;34(5):1068-72
12765033
Curr Opin Genet Dev. 2006 Jun;16(3):260-9
16647850
Am J Hum Genet. 1990 Sep;47(3):454-8
2393020
Dev Med Child Neurol. 1997 Feb;39(2):125-32
9062428
Ann Neurol. 2004 Oct;56(4):520-31
15455399
Semin Pediatr Neurol. 1998 Mar;5(1):15-20
9548636
Am J Ment Defic. 1972 May;76(6):626-31
5031083
Ment Retard Dev Disabil Res Rev. 2002;8(3):117-34
12216056
Exp Neurol. 2000 Feb;161(2):647-63
10686084
J Neurochem. 2006 Apr;97(2):475-87
16539663
Curr Opin Neurobiol. 1999 Apr;9(2):178-83
10322180
Neuromuscul Disord. 2006 Jan;16(1):19-25
16373086
Neurobiol Aging. 2004 Oct;25(9):1127-39
15312959
Curr Opin Neurobiol. 1995 Apr;5(2):161-8
7620303
Genomics. 1999 Sep 15;60(3):330-40
10493832
Mol Cell Biol. 2008 Mar;28(5):1565-72
18160706
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13983-8
10570185
Nat Rev Genet. 2005 Jan;6(1):46-57
15630421
Am J Med Genet. 2000 Fall;97(3):204-12
11449489
J Biol Chem. 2004 May 7;279(19):20369-77
14990586